Leptin increases growth of primary ossification centers in fetal mice.
The effect of peripheral leptin on fetal primary ossification centers during the early phases of bone histogenesis was investigated by administration of leptin to pregnant mice. Fourteen pregnant mice were divided into two groups. The treated pregnant group was subcutaneously injected in the intrascapular region with supraphysiologic doses (2 mg kg(-1)) of leptin (Vinci Biochem, Firenze, Italy) in a volume of 0.1 mL per 10 g body weight, at the 7th, 9th and 11th day of gestation. The control group was treated with physiological solution in the same manner and same times as the treated group. The new-born mice were killed 1 day after birth and the primary ossification centers were stained with Alizarin Red S after diaphanizing the soft tissues in 1% potassium hydroxide. The development of both endochondral and intramembranous ossification centers was morphometrically analysed in long bones. The results showed that the ossification centers of mice born by mothers treated with leptin grow more rapidly in both length and cross-sectional area compared with mice born by the untreated mothers. As the development of long bones depends on endochondral ossification occurring at proximal and distal epiphyseal plates as well as on intramembranous ossification along the periosteal surface, it appears that leptin activates the differentiation and proliferation of both chondrocytes and osteoblasts. The role of leptin as a growth factor of cartilage and bone is discussed in the light of the data reported in the literature.
Bertoni
Laura
L
Department of Anatomy and Histology - University of Modena and Reggio Emilia, Modena, Italy.
Ferretti
Marzia
M
Cavani
Francesco
F
Zavatti
Manuela
M
Resca
Elisa
E
Benelli
Augusta
A
Palumbo
Carla
C
D000818:Animals; D001842:Bone and Bones / Q000187:drug effects / Q000196:embryology*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D005260:Female; D020738:Leptin / Q000494:pharmacology*; D008431:Maternal-Fetal Exchange / Q000502:physiology; D051379:Mice; D038081:Organogenesis / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D020738:Leptin
Bone. 2005 Nov;37(5):607-21
16039170
J Endocrinol. 2002 Nov;175(2):405-15
12429038
J Bone Miner Res. 2002 Jun;17(6):1034-43
12054158
Endocrinology. 1999 Apr;140(4):1630-8
10098497
Cell. 2000 Jan 21;100(2):197-207
10660043
Peptides. 2006 Jun;27(6):1426-33
16321456
Biochem Biophys Res Commun. 1997 Nov 26;240(3):798-802
9398648
Cell. 2002 Nov 1;111(3):305-17
12419242
Endocrinology. 2005 Aug;146(8):3652-9
15845621
Annu Rev Physiol. 2000;62:413-37
10845097
J Clin Endocrinol Metab. 1997 Oct;82(10):3239-45
9329346
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564-8
8962092
Biochem Biophys Res Commun. 2001 Sep 14;287(1):190-7
11549273
Orthod Craniofac Res. 2003 Nov;6(4):233-41
14606527
Endocrinology. 2003 Jul;144(7):3024-30
12810558
Life Sci. 1998;63(16):1387-95
9952284
J Musculoskelet Neuronal Interact. 2000 Dec;1(2):133-6
15758506
Endocrinology. 2001 Aug;142(8):3546-53
11459801
J Bone Miner Res. 2002 Feb;17(2):200-9
11811550
J Histochem Cytochem. 2002 Feb;50(2):159-69
11799135
Science. 1998 Sep 11;281(5383):1683-6
9733517
Nature. 1998 Oct 22;395(6704):763-70
9796811
J Anat. 2004 Oct;205(4):291-6
15447688
Nature. 1994 Dec 1;372(6505):425-32
7984236
Regul Pept. 2000 Aug 25;92(1-3):73-8
11024568
Horm Metab Res. 1996 Dec;28(12):659-63
9013737
J Bone Miner Res. 2001 Aug;16(8):1426-33
11499865
Endocrinology. 1997 Feb;138(2):797-804
9003017
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20529-33
19074282
J Clin Endocrinol Metab. 2000 May;85(5):1997-9
10843187
Physiol Res. 2008;57 Suppl 1:S143-S151
18271682